Floatz logo

lb54640

LEPR Deficiency Obesity

LG ChemPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the LEPR Deficiency Obesity cohort.

Asset / SponsorPhaseRating
Setmelanotide
Rhythm Pharmaceuticals, Inc.
Phase 3BB

Same molecule, other indications

lb54640 is also rated in:

acquired hypothalamic obesityDormant
B
Indicative ·
57 / 100
View asset →
obesity due to prohormone convertase I deficiencyDormant
CCC
Indicative ·
53 / 100
View asset →
obesity due to pro-opiomelanocortin deficiencyDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →